bioRxivGenomicsPreprint
Integrated Metabolic Complex Genetic Interaction Network of Chromosome 4p Loss in Basal Breast Cancer
Lynn Karam, Alain PacisiD, Rohan DandageiD, Michael K. SchwartziD, Gabriel AlzialiD, Anastasia Gherghi, Haig Hugo Vrej DjambazianiD, Gerardo A. ZapataiD, Marina A. SchapfliD, Paria Asadi, Mayerly CastrilloniD, Alysh Orr, Belen Hernandez, Pegah Kargar, Michelle Vandeloo, Sylvia SantosaiD, Andreas VillungeriD, Traver HartiD, Jiannis RagoussisiD, Geneviève DebloisiD, Andreas BergdahliD, Morag ParkiD, Guillaume BourqueiD, Elena KuzminiD
Abstract
Basal breast cancer subtype is enriched for triple-negative breast cancer (TNBC) and exhibits a recurrent large chromosomal deletion in chromosome 4p (chr4p). Chr4p loss is associated with poor survival, evolves early in tumorigenesis and confers on cells a proliferative state. Here, we map the integrated metabolic complex genetic interaction network of chr4p in basal breast cancer to identify targetable vulnerabilities. Differential gene expression analysis of patient derived xenografts and cancer cell models revealed that chr4p loss is associated with changes in cellular energetics and reduction/oxidation balance. Analysis of DepMap pooled genome-wide CRISPR-Cas9 screens identified complex genetic interactions specific to chr4p deletion in basal breast cancer cell models. Functional assays revealed that chr4p loss is associated with disrupted mitochondrial respiratory function and reduced glycolytic capacity, suggesting metabolic rewiring. Increased reactive oxygen species and lipid peroxidation compromised antioxidant defense mechanisms. Ultimately, this study sheds light on targeted therapies for basal breast cancer harboring large chromosomal deletions.
- organism: human
- assay: bulk RNA-seq
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Evolution of chromosome arm aberrations in breast cancer through genetic network rewiring
Elena Kuzmin, Toby M. Baker, … Morag Park·Cell ReportsPeer-reviewed·Mar 22, 2024
- CDK4 inactivation balances resistance to apoptosis with heightened metabolic sensitivity in triple negative breast cancer cells
Dorian V. Ziegler, Kanishka Parashar, … Lluís Fajas·Nature CommunicationsPeer-reviewed·Jan 9, 2025
- CHCHD4 confers metabolic vulnerabilities to tumour cells through its control of the mitochondrial respiratory chain.
L. W. Thomas, J. M. Stephen, … M. Ashcroft·bioRxiv·Jan 7, 2019
- Absence of CD47 in the tumor microenvironment modulates tumor metabolism and immunosuppressive signatures limiting breast cancer progression.
E. R. Stirling, Y.-T. Tsai, … D. R. Soto-Pantoja·bioRxiv·Jul 12, 2023
- BRCA2 loss triggers a downward spiral of genomic instability via ROS-dependent metabolic collapse
Hayato Hirai, Tomohiro Iguchi, … Hiroyuki Sasanuma·bioRxiv·May 21, 2026
- Disruption of PI3K/OxPhos Coupling by Trehalose Drives a BCAA to Lipid Metabolic Switch in Hormone Receptor Positive Breast Cancer
Tashvinder Singh, Prabhsimran Kaur, … Sandeep Singh·bioRxiv·Apr 17, 2026